Expert Review of Neurotherapeutics

Papers
(The TQCC of Expert Review of Neurotherapeutics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men56
The relevance of cortical thickness in migraine sufferers and implications to therapy50
Steps to manage treatment-refractory migraine in adults47
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives35
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease34
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?34
The latest developments with internet-based psychological treatments for depression33
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study32
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review32
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis32
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms31
Where Art Thou O treatment for diabetic neuropathy: the sequel31
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?30
Advances in the treatment and management of frontotemporal dementia29
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202528
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents28
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia27
Acute and long-term cognitive impairment following sepsis: mechanism and prevention26
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications26
Hesitancies in primary headaches treatments25
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead25
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor25
Why is ADHD so difficult to diagnose in older adults?25
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms24
Advances in the early diagnosis of amyotrophic lateral sclerosis23
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations23
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?23
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?23
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan22
Preferences, tailoring, and self-tailoring in internet-delivered treatments: lessons learned22
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension22
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder22
Correction21
Spinal automaticity of movement control and its role in recovering function after spinal injury21
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature21
Mindfulness as a therapeutic option for obsessive-compulsive disorder20
Diagnostic advances and challenges in meningioma20
Current use of neurotoxins for alleviating symptoms of cervical dystonia19
The impact of sleep apnea on epilepsy treatment outcomes19
Virtual reality technology in the treatment of anxiety – progress and future challenges19
Multimodal approaches to the treatment of personality disorder19
Advances in gene therapy for high-grade glioma: a review of the clinical evidence18
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients18
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound18
Navigating long-acting antipsychotic decision-making in schizophrenia: clinical considerations and best practices18
Illuminating the way: the role of bright light therapy in the treatment of depression17
Considerations for hormonal therapy in migraine patients: a critical review of current practice17
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review17
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy17
Cross-national reflections on medicinal cannabis and depression16
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools16
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective16
Cognitive and motivational therapy for problematic alcohol use and alcohol use disorder in older adults: a systematic review16
The differential diagnosis of autism spectrum disorder in adults16
A novel treatment option for intrajejunal levodopa administration16
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)16
Long-term outcomes in refractory status epilepticus15
Daridorexant: exploring its role in the treatment of insomnia disorder15
Considering hearing loss as a modifiable risk factor for dementia15
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes15
An overview of current and emerging strategies for phantom limb pain15
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts15
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies15
Frontotemporal dementia. How to deal with its diagnostic complexity?15
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?14
Thymectomy in myasthenia gravis: timing and indications14
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor14
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature14
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?13
Do people with bipolar disorder have a greater risk of dementia in later life?13
An update on the developments and challenges with the diagnosis and classification of autoimmune optic neuritis13
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability13
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence13
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions13
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond13
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease13
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis13
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes13
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions12
Could self-reporting sleep duration become an important tool in the prediction of dementia?12
Therapeutic issues in Guillain–Barré syndrome12
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?12
When and in what patient segments are low-intensity and remote interventions valuable for treating symptoms of post-concussion syndrome12
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?12
Developments in targeting calcitonin gene-related peptide12
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression12
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper11
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”11
Exploring the differential diagnosis of generalized diabetic peripheral neuropathy11
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions11
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain 11
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?11
Stem cell therapy for patients with paraplegia: is there hope for the future?11
Bipolar disorder staging and the impact it has on its management: an update11
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?11
Understanding the genetic risk of schizophrenia10
Rethinking the role of trazodone in the different depressive dimensions10
Long-term central nervous system (CNS) consequences of COVID-19 in children10
Contemporary perspectives in cerebral amyloid angiopathy10
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease10
What place does daridorexant have in the treatment of Binge-Eating Disorder?10
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review10
Learnings in developmental and epileptic encephalopathies: what do we know?9
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications9
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments9
Treating the root cause of tension-type headache: when analgesics address the symptom but not the disorder9
The major challenges with pharmacologic management of chronic traumatic encephalopathy9
Tobacco use disorder and depression: emerging strategies and recommendations:9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis9
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis9
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review9
The challenges and opportunities related to the therapeutic use of music in psychiatry9
Is transcranial direct current stimulation a viable treatment option for fibromyalgia?9
Deep brain stimulation: new programming algorithms and teleprogramming9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations9
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures9
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis9
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)9
Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates: a plain language summary of publication9
The value of radiotherapy in patients with recurrent atypical meningioma: an update9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions9
0.61888790130615